• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global BCL-2 (B-cell lymphoma 2) inhibitors market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global BCL-2 (B-cell lymphoma 2) inhibitors market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 Type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Combination therapy – Market size and forecast 2022-2027
o Exhibit 34: Chart on Combination therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Combination therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Combination therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Combination therapy – Year-over-year growth 2022-2027 (%)
o 6.4 Monotherapy – Market size and forecast 2022-2027
o Exhibit 38: Chart on Monotherapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Monotherapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Monotherapy – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Monotherapy – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 44: Chart on Type – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Type – Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 46: Chart on Comparison by Type
o Exhibit 47: Data Table on Comparison by Type
o 7.3 Diffuse large B-cell lymphoma (DLBCL) – Market size and forecast 2022-2027
o Exhibit 48: Chart on Diffuse large B-cell lymphoma (DLBCL) – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Diffuse large B-cell lymphoma (DLBCL) – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Diffuse large B-cell lymphoma (DLBCL) – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Diffuse large B-cell lymphoma (DLBCL) – Year-over-year growth 2022-2027 (%)
o 7.4 Follicular lymphoma – Market size and forecast 2022-2027
o Exhibit 52: Chart on Follicular lymphoma – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Follicular lymphoma – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Follicular lymphoma – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Follicular lymphoma – Year-over-year growth 2022-2027 (%)
o 7.5 Chronic lymphocytic leukemia – Market size and forecast 2022-2027
o Exhibit 56: Chart on Chronic lymphocytic leukemia – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Chronic lymphocytic leukemia – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Chronic lymphocytic leukemia – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Chronic lymphocytic leukemia – Year-over-year growth 2022-2027 (%)
o 7.6 Mantle cell lymphoma (MCL) – Market size and forecast 2022-2027
o Exhibit 60: Chart on Mantle cell lymphoma (MCL) – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Mantle cell lymphoma (MCL) – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Mantle cell lymphoma (MCL) – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Mantle cell lymphoma (MCL) – Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Type
o Exhibit 64: Market opportunity by Type ($ million)
o Exhibit 65: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share by geography 2022-2027 (%)
o Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 71: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 87: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Canada – Market size and forecast 2022-2027
o Exhibit 91: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 99: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 France – Market size and forecast 2022-2027
o Exhibit 103: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 107: Market opportunity by geography ($ million)
o Exhibit 108: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 115: AbbVie Inc. – Overview
o Exhibit 116: AbbVie Inc. – Product / Service
o Exhibit 117: AbbVie Inc. – Key news
o Exhibit 118: AbbVie Inc. – Key offerings
o 12.4 Abcam plc
o Exhibit 119: Abcam plc – Overview
o Exhibit 120: Abcam plc – Product / Service
o Exhibit 121: Abcam plc – Key news
o Exhibit 122: Abcam plc – Key offerings
o 12.5 Amgen Inc.
o Exhibit 123: Amgen Inc. – Overview
o Exhibit 124: Amgen Inc. – Product / Service
o Exhibit 125: Amgen Inc. – Key offerings
o 12.6 Ascentage Pharma Group International
o Exhibit 126: Ascentage Pharma Group International – Overview
o Exhibit 127: Ascentage Pharma Group International – Product / Service
o Exhibit 128: Ascentage Pharma Group International – Key offerings
o 12.7 AstraZeneca Plc
o Exhibit 129: AstraZeneca Plc – Overview
o Exhibit 130: AstraZeneca Plc – Product / Service
o Exhibit 131: AstraZeneca Plc – Key news
o Exhibit 132: AstraZeneca Plc – Key offerings
o 12.8 BeiGene Ltd.
o Exhibit 133: BeiGene Ltd. – Overview
o Exhibit 134: BeiGene Ltd. – Business segments
o Exhibit 135: BeiGene Ltd. – Key offerings
o Exhibit 136: BeiGene Ltd. – Segment focus
o 12.9 Bio Techne Corp.
o Exhibit 137: Bio Techne Corp. – Overview
o Exhibit 138: Bio Techne Corp. – Business segments
o Exhibit 139: Bio Techne Corp. – Key news
o Exhibit 140: Bio Techne Corp. – Key offerings
o Exhibit 141: Bio Techne Corp. – Segment focus
o 12.10 Biorbyt Ltd.
o Exhibit 142: Biorbyt Ltd. – Overview
o Exhibit 143: Biorbyt Ltd. – Product / Service
o Exhibit 144: Biorbyt Ltd. – Key offerings
o 12.11 Bristol Myers Squibb Co.
o Exhibit 145: Bristol Myers Squibb Co. – Overview
o Exhibit 146: Bristol Myers Squibb Co. – Product / Service
o Exhibit 147: Bristol Myers Squibb Co. – Key news
o Exhibit 148: Bristol Myers Squibb Co. – Key offerings
o 12.12 F. Hoffmann La Roche Ltd.
o Exhibit 149: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 150: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 151: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 152: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 153: F. Hoffmann La Roche Ltd. – Segment focus
o 12.13 Merck and Co. Inc.
o Exhibit 154: Merck and Co. Inc. – Overview
o Exhibit 155: Merck and Co. Inc. – Business segments
o Exhibit 156: Merck and Co. Inc. – Key news
o Exhibit 157: Merck and Co. Inc. – Key offerings
o Exhibit 158: Merck and Co. Inc. – Segment focus
o 12.14 Novartis AG
o Exhibit 159: Novartis AG – Overview
o Exhibit 160: Novartis AG – Business segments
o Exhibit 161: Novartis AG – Key offerings
o Exhibit 162: Novartis AG – Segment focus
o 12.15 Santa Cruz Biotechnology Inc.
o Exhibit 163: Santa Cruz Biotechnology Inc. – Overview
o Exhibit 164: Santa Cruz Biotechnology Inc. – Product / Service
o Exhibit 165: Santa Cruz Biotechnology Inc. – Key offerings
o 12.16 Seagen Inc.
o Exhibit 166: Seagen Inc. – Overview
o Exhibit 167: Seagen Inc. – Product / Service
o Exhibit 168: Seagen Inc. – Key offerings
o 12.17 Servier
o Exhibit 169: Servier – Overview
o Exhibit 170: Servier – Business segments
o Exhibit 171: Servier – Key offerings
o Exhibit 172: Servier – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 173: Inclusions checklist
o Exhibit 174: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 175: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 176: Research methodology
o Exhibit 177: Validation techniques employed for market sizing
o Exhibit 178: Information sources
o 13.5 List of abbreviations
o Exhibit 179: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global BCL-2 (B-cell lymphoma 2) inhibitors market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Combination therapy – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Combination therapy – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Combination therapy – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Combination therapy – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Monotherapy – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Monotherapy – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Monotherapy – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Monotherapy – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Type – Market share 2022-2027 (%)
Exhibits45: Data Table on Type – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Diffuse large B-cell lymphoma (DLBCL) – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Diffuse large B-cell lymphoma (DLBCL) – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Diffuse large B-cell lymphoma (DLBCL) – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Diffuse large B-cell lymphoma (DLBCL) – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Follicular lymphoma – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Follicular lymphoma – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Follicular lymphoma – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Follicular lymphoma – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Chronic lymphocytic leukemia – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Chronic lymphocytic leukemia – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Chronic lymphocytic leukemia – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Chronic lymphocytic leukemia – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Mantle cell lymphoma (MCL) – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Mantle cell lymphoma (MCL) – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Mantle cell lymphoma (MCL) – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Mantle cell lymphoma (MCL) – Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Type ($ million)
Exhibits65: Data Table on Market opportunity by Type ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2022-2027 (%)
Exhibits68: Data Table on Market share by geography 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity by geography ($ million)
Exhibits108: Data Tables on Market opportunity by geography ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. – Overview
Exhibits116: AbbVie Inc. – Product / Service
Exhibits117: AbbVie Inc. – Key news
Exhibits118: AbbVie Inc. – Key offerings
Exhibits119: Abcam plc – Overview
Exhibits120: Abcam plc – Product / Service
Exhibits121: Abcam plc – Key news
Exhibits122: Abcam plc – Key offerings
Exhibits123: Amgen Inc. – Overview
Exhibits124: Amgen Inc. – Product / Service
Exhibits125: Amgen Inc. – Key offerings
Exhibits126: Ascentage Pharma Group International – Overview
Exhibits127: Ascentage Pharma Group International – Product / Service
Exhibits128: Ascentage Pharma Group International – Key offerings
Exhibits129: AstraZeneca Plc – Overview
Exhibits130: AstraZeneca Plc – Product / Service
Exhibits131: AstraZeneca Plc – Key news
Exhibits132: AstraZeneca Plc – Key offerings
Exhibits133: BeiGene Ltd. – Overview
Exhibits134: BeiGene Ltd. – Business segments
Exhibits135: BeiGene Ltd. – Key offerings
Exhibits136: BeiGene Ltd. – Segment focus
Exhibits137: Bio Techne Corp. – Overview
Exhibits138: Bio Techne Corp. – Business segments
Exhibits139: Bio Techne Corp. – Key news
Exhibits140: Bio Techne Corp. – Key offerings
Exhibits141: Bio Techne Corp. – Segment focus
Exhibits142: Biorbyt Ltd. – Overview
Exhibits143: Biorbyt Ltd. – Product / Service
Exhibits144: Biorbyt Ltd. – Key offerings
Exhibits145: Bristol Myers Squibb Co. – Overview
Exhibits146: Bristol Myers Squibb Co. – Product / Service
Exhibits147: Bristol Myers Squibb Co. – Key news
Exhibits148: Bristol Myers Squibb Co. – Key offerings
Exhibits149: F. Hoffmann La Roche Ltd. – Overview
Exhibits150: F. Hoffmann La Roche Ltd. – Business segments
Exhibits151: F. Hoffmann La Roche Ltd. – Key news
Exhibits152: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits153: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits154: Merck and Co. Inc. – Overview
Exhibits155: Merck and Co. Inc. – Business segments
Exhibits156: Merck and Co. Inc. – Key news
Exhibits157: Merck and Co. Inc. – Key offerings
Exhibits158: Merck and Co. Inc. – Segment focus
Exhibits159: Novartis AG – Overview
Exhibits160: Novartis AG – Business segments
Exhibits161: Novartis AG – Key offerings
Exhibits162: Novartis AG – Segment focus
Exhibits163: Santa Cruz Biotechnology Inc. – Overview
Exhibits164: Santa Cruz Biotechnology Inc. – Product / Service
Exhibits165: Santa Cruz Biotechnology Inc. – Key offerings
Exhibits166: Seagen Inc. – Overview
Exhibits167: Seagen Inc. – Product / Service
Exhibits168: Seagen Inc. – Key offerings
Exhibits169: Servier – Overview
Exhibits170: Servier – Business segments
Exhibits171: Servier – Key offerings
Exhibits172: Servier – Segment focus
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations
